An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells. [electronic resource]
Producer: 20110826Description: 1410-7 p. digitalISSN:- 1349-7006
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- drug therapy
- Bromodeoxyuridine -- metabolism
- Cell Line, Tumor
- Cisplatin -- pharmacology
- DNA-Binding Proteins -- analysis
- Dose-Response Relationship, Drug
- Drug Resistance
- Female
- Humans
- Nuclear Proteins -- analysis
- RNA, Small Interfering -- genetics
- Ribosomal Proteins -- analysis
- Y-Box-Binding Protein 1
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.